Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List

High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure. We checked if FGF23 concentration could be modified in patients with end stage liver disease (ESLD) and predict mortality. We m...

Descripción completa

Detalles Bibliográficos
Autores principales: Prié, Dominique, Forand, Anne, Francoz, Claire, Elie, Caroline, Cohen, Isabelle, Courbebaisse, Marie, Eladari, Dominique, Lebrec, Didier, Durand, François, Friedlander, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692511/
https://www.ncbi.nlm.nih.gov/pubmed/23825530
http://dx.doi.org/10.1371/journal.pone.0066182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692511/
https://www.ncbi.nlm.nih.gov/pubmed/23825530
http://dx.doi.org/10.1371/journal.pone.0066182

Ejemplares similares